Table 2.
Clinical and demographic characteristics of patients with cirrhosis for Study 2.
| N | Group A2 (n = 92) | Group N (n = 27) | Group C (n = 116) | P value |
| Gender (male/female) | 83/9 | 14/13 | 60/56 | .04 |
| Age∗ | 65 ± 10 | 70 ± 9 | 72 ± 9 | .02 |
| Child-Pugh classification (A/B/C) | 57/29/6 | 18/7/2 | 73/36/5 | .06 |
| Sarcopenia/non-sarcopenia | 32/60 | 8/19 | 37/79 | .85 |
| Sarcopenia obesity/non-sarcopenia obesity | 10/82 | 3/24 | 5/111 | .17 |
| Ascites grade 0/1/2/3 | 73/16/3/0 | 21/5/1/0 | 90/18/7/1 | .93 |
| Hepatic encephalopathy grade 0/1/2/3 | 88/3/1/0 | 25/2/0/0 | 108/8/0/0 | .87 |
| BMI (kg/m2)∗ | 23.8 ± 4.8 | 27.7 ± 7.8 | 22.7 ± 4.1 | .02 |
| PT (%)∗ | 70 ± 15 | 68 ± 13 | 72 ± 13 | .08 |
| Alb (g/dL)∗ | 3.7 ± 0.6 | 3.7 ± 0.6 | 3.6 ± 0.7 | .42 |
| T-Bil (mg/dL)∗ | 1.1 ± 0.2 | 0.9 ± 0.1 | 1.3 ± 0.2 | .73 |
| T-Cho (mg/dL)∗ | 161 ± 39 | 160 ± 37 | 149 ± 41 | .09 |
| Ch-E (U/L)∗ | 202 ± 87 | 213 ± 75 | 165 ± 83 | .04 |
| TG (mg/dL)∗ | 85 ± 45 | 93 ± 40 | 89 ± 51 | .63 |
| BTR (μmol/L)∗ | 4.6 ± 2.1 | 4.7 ± 2.0 | 4.5 ± 1.7 | .65 |
| Ammonia (μg/dL)∗ | 51 ± 31 | 49 ± 31 | 43 ± 27 | .51 |
| Zn (μg/dL)∗ | 68 ± 17 | 49 ± 22 | 64 ± 19 | .11 |
| EA levels∗ | 0.30 ± 0.11 | 0.33 ± 0.14 | 0.31 ± 0.12 | .17 |